Respiratory Medicine
Volume 104, Issue 5 , Pages 697-704, May 2010

Economic implications of comorbid conditions among Medicaid beneficiaries with COPD☆

  • Pei-Jung Lin

      Affiliations

    • Center for the Evaluation of Value and Risk in Health, Institute for Clinical Research and Health Policy Studies, Tufts Medical Center, Boston, MA 02111, USA
    • Corresponding Author InformationCorresponding author. Tel.: +1 617 636 4616; fax: +1 617 636 5560.
    • ,
  • Fadia T. Shaya

      Affiliations

    • Department of Pharmaceutical Health Services Research, University of Maryland School of Pharmacy, Baltimore, MD 21201, USA
    • ,
  • Steven M. Scharf

      Affiliations

    • Division of Pulmonary and Critical Care Medicine, University of Maryland Sleep Disorders Center, Baltimore, MD 21201, USA

Received 22 June 2009; accepted 15 November 2009. published online 03 December 2009.

To access this article, please choose from the options below

Login to an existing account or Register a new account.

  • Purchase this article for 31.50 USD (You must login/register to purchase this article)

    Online access for 24 hours. The PDF version can be downloaded as your permanent record.

  • Subscribe to this title

    Get unlimited online access to this article and all other articles in this title 24/7 for one year.

  • Claim access now

    For current subscribers with Society Membership or Account Number.

  • Visit SciVerse ScienceDirect to see if you have access via your institution.

☆ An abstract of this manuscript was presented at the International Society for Pharmacoeconomics and Outcomes Research 14th Annual International Meeting, May 16–20, 2009.

PII: S0954-6111(09)00373-4

doi:10.1016/j.rmed.2009.11.009

Respiratory Medicine
Volume 104, Issue 5 , Pages 697-704, May 2010

Article Tools